Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €94.50 | €109.94 | 16.343% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.96 | €26.95 | 145.891% |
| Edwards Lifesciences Corp. | 27 | 1 | 4 | 0 | €81.08 | €88.17 | 8.744% |
| Cytokinetics Inc. | 31 | 1 | 8 | 0 | €44.60 | €83.13 | 86.393% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.40 | €47.17 | 16.757% |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | €6.20 | €8.27 | 33.432% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €166.05 | €215.54 | 29.803% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €117.05 | €147.62 | 26.114% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €10.28 | €27.80 | 170.467% |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.23 | €8.36 | 158.675% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €31.40 | €38.99 | 24.168% |
| Radnet Inc. | 9 | 3 | 2 | 0 | €54.00 | €54.58 | 1.075% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.68 | €4.62 | 580.560% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €60.50 | €79.55 | 31.495% |
| Akebia Therapeutics Inc. | 8 | 2 | 0 | 0 | €1.02 | €3.64 | 257.645% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €37.40 | €84.74 | 126.588% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.50 | - | - |
| Abeona Therapeutics Inc. | 4 | 1 | 1 | 0 | €3.76 | €33.73 | 797.032% |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | €19.63 | €20.00 | 1.885% |
| Agilent Technologies Inc. | 10 | 3 | 0 | 0 | €138.82 | €133.39 | -3.915% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €305.60 | €369.72 | 20.983% |
| Syros Pharmaceuticals Inc. | 6 | 1 | 1 | 0 | €4.76 | €13.60 | 185.662% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.41 | €6.03 | 36.647% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €156.78 | €200.06 | 27.604% |
| Atossa Genetics Inc | 7 | 1 | 2 | 0 | €1.35 | €3.74 | 177.831% |